Michelle M. Hanna

Biography

Dr. Hanna, the founder and CEO of Ribomed Biotechnologies, received her Ph.D. in Chemistry from the University of California, Davis and did her postdoctoral work in Biochemistry and Molecular Genetics as an American Cancer Society Postdoctoral Fellow at the University of California, Berkeley. She was an Assistant Professor of Biological Chemistry at UC Irvine College of Medicine where she received Young Investigator awards from the American Cancer Society and the Beckman Foundation. Dr. Hanna was a tenured Associate Professor of Chemistry and Biochemistry at the University of Oklahoma until she founded Ribomed Biotechnologies. Dr. Hanna has been awarded over $10 million in grants and contracts from the American Cancer Society, the National Cancer Institute (NCI)/National Institutes of Health (NIH), the National Science Foundation (NSF), the National Institute of Allergies and Infectious Diseases (NIAID)/NIH, the Defense Advanced Research Projects Agency (DARPA), and the Homeland Security Advanced Projects Agency (HSARPA). Her work has resulted in numerous peer-reviewed publications and book chapters and 30 issued and pending patents.

Research Interest

DNA methylation biomarkers, Coupled Abscription PCR Signalling